XRP gains clarity, TON leads growth, ADA stumbles, and CRO surprises with an ETF twist. Here’s what’s driving the crypto ...

Up to $3 billion in pharmaceuticals currently used in the United States (U.S.) depend on Canadian manufacturing, according to new research findings from the University of Toronto. Applying 25% trade ...

SUI is one of the few altcoins resilient to recent downturns, holding steady for the week with a 0.5% gain—making its claim ...

XRP currently trades around $2.05 with analysts predicting a potential rise to $5-$27 in the coming months based on technical ...

Analysts' ratings for Alnylam Pharmaceuticals ALNY over the last quarter vary from bullish to bearish, as provided by 27 ...

A Glimpse into Anfield’s Latest MovesLiverpool’s approach to bolstering its squad has often mirrored a chess game, ...

AbbVie is grappling with diminishing Humira sales and is also trading at an above-average P/E. See why I rate ABBV stock as a ...

The Solana price prediction shows that SOL is struggling to break above key moving averages, with a potential bullish ...

EnerSys, a leading U.S. industrial battery maker, benefits from electrification, automation & data center growth, ensuring ...

Open Lending Corp is engaged in providing automated lending services to financial institutions. The company offers loan ...

U.S. President Donald Trump's scheduled April 2 tariff policy announcement could clear a fog of uncertainty that has clouded ...

XRP stands at a crossroads with regulatory clarity, stablecoin growth, and rising competition—explore its prospects and risks ...